factual
Argenx's competition is changing standard of care
For autoimmune diseases with high unmet need, the main competition is not other companies but changing standard of care and doctors' mindsets, though later competitors such as UCB and J&J will target the same biology.
factualpending
Speaker
JuliaEvidence Quote
“it's more competition of changing the standard of care”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...